Weekly Funding Opps

Foundation

• Alex's Lemonade Stand
  Early Career Research Programs
• Union for International Cancer Control UICC
  Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
  opens autumn 2023
• Gray Foundation
  GRAY FOUNDATION BRCA TEAM SCIENCE PROGRAM
• Prostate Cancer Foundation
  Prostate Cancer Foundation Awards (Various)
  Deadlines vary across grants
• Lung Cancer research Foundation (LCRF)
  LCRF (various)
• Memorial Sloan Kettering Cancer Center
  Clinical Chemistry Fellowship
  Applications will be accepted until the position is filled. Early application is encouraged.
• St. Baldrick's Foundation
  St. Baldrick's Foundation Spring Grant Cycle
  Deadlines vary across awards
• American Cancer Society
  American Cancer Society Grants (various)
  Deadlines April 1 and October 15
• Melanoma Research Foundation
  Melanoma Research Foundation RFP (various)
  Due dates vary by grant
• Pew
  Pew-Stewart Scholars for Cancer Research
• Society for Immunology of Cancer
  2024 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
• Colorectal Cancer Alliance
  Project Cure CRC
  rolling request for proposals
• OREF
  OREF Research Grants (various)
• American Cancer Society
  Extramural Discovery Science Accelerator Award
  Applications submitted through June 1, will be reviewed in July. Applications submitted after June 1, will be reviewed in December. Grants start in September 2025 (July review) or 04/2026 (December)
• Children's Cancer Research Fund (CCRF)
  Children's Cancer Research Fund Research Grant (various)
• The Hope Foundation
  SWOG Trial Support (STrS)
• American Lung Association
  American Lung Association (various)
  due dates vary -- see application for each award
• American Association for Cancer Research (AACR)
  AACR MINORITY SCHOLAR IN CANCER RESEARCH AWARDS
• Alan B. Slifka Foundation
  Sarcoma Research Grants Initiative
  send a 1-2 page letter of intent (LOI) to sarcomaLOI@slifkafoundation.org.
• Society for Immunology of Cancer
  SITC-Merck Cancer Immunotherapy Clinical Fellowship
• Robert A. Winn Diversity in Clinical Trials Award Program
  Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA)
• Cholangiocarcinoma Foundation
  Cholangiocarcinoma Foundation Research Fellowship Program
  LOI due: 08/11/2023
• Melanoma Research Alliance
  Melanoma Research Alliance RFP
  LOI due: 09/20/2023
• Cancer Prevention Initiative
  CPI 2023-24 Research Grants – Request for Proposals
  LOI due: 10/15/2023
• The Mark Foundation
  Endeavor Award
  LOI due: 03/12/2024
• The Mark Foundation
  The Mark Foundation Emerging Leader Award
  LOI due: 04/29/2024
• Breast Cancer Alliance
  Exceptional Project Grants
  LOI due: 03/31/2025
• Pfizer
  Diagnosis and Treatment of Cancer Cachexia
  Application Due: 05/13/25
• American Association for Cancer Research (AACR)
  AACR-ALK Positive Lung Cancer Research Fellowship
  Application Due: 05/15/25
• Alliance for Cancer Gene Therapy
  2025 Investigator Award in Cell and Gene Therapy for Gynecological Cancer Research
  Application Due: 05/16/25
• American Association for Cancer Research (AACR)
  AACR Grant For Innovative Bladder Cancer Research
  Application Due: 06/05/25
• The Mark Foundation
  Early Detection Award
  LOI due: 03/10/2025
  Application Due: 06/17/25
• American Association for Cancer Research (AACR)
  AACR-Novocure Cancer Research Grant
  Application Due: 06/30/25
• American Association for Cancer Research (AACR)
  AACR-Novocure Career Development Award for Cancer Research
  Application Due: 06/30/25
• Fibrolamellar Cancer Foundation
  Fibrolamellar Cancer Foundation Research Grant Program
  Application Due: 07/01/25
• Patient Centered Outcomes Research Institute
  Phased Large Awards for Comparative Effectiveness Research PCORI Funding Announcement -- Cycle 2 2025
  LOI due: 05/13/2025
  Application Due: 09/03/25

Internal

• UMGCCC
  Student/trainee supplements for PIO faculty to mentor undergraduate or high school trainees
  $1,200/trainee to offset expenses (e.g. supplies, stipends)
• UMGCCC
  UMGCCC research mentors for teachers in NCI CATALYST (CURE) program
  please contact Bret Hassel if interested (bhassel@som.umaryland.edu)
• NIH
  Administrative Supplement Funding Opportunities
  If interested in applying, please send Sarah Laye a 1-page abstract and NIH biosketches of key personnel by Friday, 3/15/24.
• UMSOM
  Large Grant Acceleration Program (LGAP)
• V Foundation
  Future V Foundation Opportunities
  contact Sarah Laye for more information at slaye@som.umaryland.edu
• US Department of Veteran Affairs (VA)
  VA opportunities

  If interested in obtaining the PDF version of a particular VA opportunity and to inquire on eligibility, please email Natalie Dugger (Natalie.Dugger@va.gov) and cc Sarah Laye (slaye@som.umaryland.edu) on your request. Note that VA opportunities are specific and you must confirm eligibility with the VA.

  Deadline varies by grant

MDH

• Maryland Department of Health
  MHHD Grant Programs
  see each grant for specific deadline

• Society for Immunotherapy of Cancer
  SITC-MRA Women in Melanoma Fellowship Award

Prize

• Pershing Square Foundation
  MIND Prize
  LOI due: 11/13/2023

NIH

• NCI
  National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
  LOI due 30 days before application due date
  Standard due dates apply
• NCI
  NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
  Applications are accepted by continuous receipt.
• NCI
  Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
  Standard due dates apply
• NCI
  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
  Standard due dates apply
• NCI
  Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
  LOI due 30 days before application due date
  Standard due dates apply
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  Standard due dates apply
• NIH
  Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
  Standard due dates apply
• NCI
  Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
  Standard due dates apply
• NCI
  Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required)
  Standard due dates apply
• NIH
  Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
  Standard due dates apply
• NIH
  PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
  Standard due dates apply
• NIH
  The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
  no LOI required
  Standard due dates apply
• NCI
  Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
  Standard due dates apply
• NIH
  HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  LOI due 30 days before application due date
  Standard due dates apply
• NIH
  P30 Administrative Supplements NOFOs (various)
  please send 1 page abstract and NIH biosketch to Sarah Laye if interested. One application per NOFO.
• NCI
  Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  Standard due dates apply
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
  Standard due dates apply
• NIH
  PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
  Standard due dates apply
• NCI
  Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
  Standard due dates apply
• NIH
  PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
  Standard due dates apply
• NIH
  Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
  Application Due: 07/01/25
• NCI
  Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
  Standard due dates apply

NIH NOSI

• NIH
  Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology
  Application Due: 05/07/25
• NCI
  Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
  Application Due: 07/01/25
• NCI
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NIH
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NIH
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NCI
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NCI
  Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable
  Application Due: 10/01/25
• NCI
  Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
  Application Due: 11/18/25
• NCI
  Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
  Application Due: 11/18/25
• NIH
  Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
  Application Due: 01/08/26
• NCI
  Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
  Application Due: 03/17/26
• NCI
  Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
  Application Due: 05/09/26
• NCI
  Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
  Application Due: 05/09/26
• NIH
  Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
  Application Due: 06/06/26
• NIH
  Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities
  Application Due: 06/06/26
• NIH
  Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
  Application Due: 06/06/26
• NCI
  Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
  Application Due: 09/08/26
• NCI
  Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities
  Application Due: 10/10/26
• NCI
  Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities
  Application Due: 10/10/26
• NIH
  Notice of Special Interest (NOSI): Promoting Data Reuse for Health Research
  Application Due: 11/04/26
• NIAID
  Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
  Application Due: 11/17/26
• NCI
  Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)
  Application Due: 11/17/26
• NCI
  Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies
  Application Due: 01/08/27
• NCI
  Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications
  Application Due: 01/27/27
• NIH
  Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)
  Application Due: 01/27/27
• NCI
  Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease
  Application Due: 05/10/27
• NIH
  Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
  Application Due: 07/14/27
• NCI
  Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research
  Application Due: 07/31/27
• NCI
  Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
  Application Due: 11/14/27
• NIH
  Notice of Special Interest (NOSI): Communication and Decision-Making in a Complex and Dynamic Cancer Treatment Environment
  Application Due: 09/08/28
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
  Application Due: 05/08/29
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
  Application Due: 05/08/29
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
  Application Due: 05/08/29
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
  Application Due: 05/08/29

DOD

• DOD
  DOD 2023 Breast Cancer Research Program (BCRP)
• DOD
  FY23 DoD Melanoma Grants
  Deadlines vary across awards
• DOD
  FY23 Ovarian Cancer Research Program (OCRP) (various)
  Deadlines vary across awards

COVID

• UMB SOM Office of Research Career Development
  Funding for Research on COVID-19 and Information for NIH Applicants re: Impact of COVID-19 on Grants and Submissions
• UM VENTURES
  UMCP / UMB Coronavirus Medical Device Challenge Program
  Applications will be accepted on a rolling basis through May 2020 (or until funds are exhausted); funding decisions will be made bi-weekly until all funds are spent.
• University of Maryland Baltimore, Institute for Clinical & Translational Research (UMB ICTR)
  Special Call for COVID-19 ICTR Voucher Applications
  Applications will be accepted on a rolling basis.
• NIH
  Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
  Expiration Date: 9/8/24.